Groowe Groowe / Newsroom / MRK
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

MRK News

Merck & Co., Inc.

Vaxxas Appoints Former Merck Global Vaccines President David Peacock as CEO

globenewswire.com
MRK MSD

Immuno-Oncology Drugs Market Projected to Reach US$ 185.69 Billion by 2035 | Astute Analytica

globenewswire.com
VRTX MRK BMY GILD JNJ AZN NVS REGN AMGN PFE BIIB ISRG MDLZ IMCR CRSP EDIT NCLH ACRS ALNY INCY ABBV LULU EXAS RDVY ONCY GENM DTIL XAIR CGEN ADPT ATRC CODX CORT CRBU CTAS CYTK DASH DECK DOCU EBAY ELAN ENPH EPAM FIVN FORM FTNT GDRX GEHC GNTX GOOS GRMN GTLB HGV HLT HOLX HON HPE HPQ HRB HSIC HWM IDXX ILMN INSM INTC INTU IRTC ITRI IVZ JBL JEF JHG JLL JPM KDP KHC KODK LAKE LCID LRCX LSCC LYFT MCHP MELI MGM MKTX MLCO MNST MRVL MTCH MU NDSN NEO NET NFLX NKE NOC NOW NRG NTAP NTES NVDA NXPI ODFL OMC ON ORCL ORLY OSK OTIS OXY PANW PAYX PCAR PCG PDD PEP PGR PH PHG PII PKX PLAB PLD PLUG PM PNW POOL POST PPG PPL PRGS PRGO PRLB PRO PRTA PSFE PSNY PTC PVH QCOM QGEN QRVO RBLX RCL RDNT REI REIT RF RGEN RIVN RL RMBS RMD ROBT ROKU ROST RPRX RS RSG RSP RVSN RYAAY S SABR SAN SAVA SBAC SBRA SBUX SCHD SCL SD SE SEDG SEE SEIC SELF SEM SIRI SJM SKX SLB SLGN SMCI SMLR SNBR SNOW SNPS SO SONO SPCE SPGI SPNS SQM SRPT SSNC ST STAG STLD STNG STOK STX SUN SWKS SYK SYY T TAL TAN TCOM TDOC TECK TEF TEK TEL TER TFX TGT TGTX THC THO TIGR TITN TJX TLRY TMO TMUS TNDM TNET TOL TOPS TORO TPH TPL TQQQ TR TRC TRIP TRMB TRMK TRN TRP TRT TRVG TS TSCO TSE TSLA TSN TT TTC TTD TTI TTNP TTWO TU TUSK TV TVC TVE TW TWLO TX TXN TXRH TXT TYL U UAL UBER UDR UEC UHAL ULTA UMC UMH UNFI UNH UNIT UNM UPST URBN USA USFD USNA USPH UTHR V VRSK VTR VTRS VZ W WAB WDC WEC WELL WEN WERN WEX WFC WGO WHD WHR WIA WMB WMT WNS WPC WRB WST WTAI WTFC WTS WU WY WYNN XBIT XCUR XENE XFLT XGN XHR XLP XOM XPO XRAY XRT XTLB XXII XYL YETI YMM YPF YUM Z ZBRA ZCMD ZIM ZION ZKIN ZNTL ZTO ZTS ZYME

Animal parasiticides market to grow at a CAGR of 6% during the forecast period (2025 – 2030): Wissen Research

globenewswire.com
ZTS ELAN MRK

Merck Initiates Phase 3 KANDLELIT-007 Trial Evaluating Calderasib (MK-1084), an Investigational Oral KRAS G12C Inhibitor, in Combination With KEYTRUDA QLEX™ (pembrolizumab and berahyaluronidase alfa-pmph) in Certain Patients With Advanced NSCLC

businesswire.com
MRK

Merck to Complete Acquisition of Cidara Therapeutics

businesswire.com
MRK CDTX

Merck to Hold Fourth-Quarter and Full-Year 2025 Sales and Earnings Conference Call Feb. 3

businesswire.com
MRK

TIGIT Inhibitors Drugs Clinical Trials & Global Market Opportunity Report 2026-2030: Roche, Gilead Sciences, Merck, Arcus Biosciences, Compugen, and Vir Biotechnology Advance Deep Oncology Pipelines

globenewswire.com
GILD MRK ARCX CGEN VIR

Industry Veteran Jonathan Freeman, Ph.D. Joins ARTBIO As Chief Business Officer

prnewswire.com
MRK BAX

Marquis Who's Who Honors Marina Derosa as a Leader in Business Management

accessnewswire.com
JNJ MRK BP

Merck to Participate in the 44th Annual J.P. Morgan Healthcare Conference

businesswire.com
MRK